nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Photosensitivity reaction—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Weight increased—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Epistaxis—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Methotrexate—bone cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Weight decreased—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Sinusitis—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Pneumonia—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Drowsiness—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Infestation—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Visual impairment—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Cisplatin—bone cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Bradycardia—Epirubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Rhinitis—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Dexmethylphenidate—Eye disorder—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Dexmethylphenidate—Asthenia—Cisplatin—bone cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Angiopathy—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Visual impairment—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Chills—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Cisplatin—bone cancer	0.00111	0.00111	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Dexmethylphenidate—Alopecia—Methotrexate—bone cancer	0.00111	0.00111	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Mental disorder—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Eye disorder—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Malnutrition—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Erythema—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Flushing—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Angiopathy—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Back pain—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Chills—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Dexmethylphenidate—Alopecia—Epirubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Dexmethylphenidate—Vomiting—Cisplatin—bone cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Vision blurred—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Mental disorder—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Rash—Cisplatin—bone cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Dermatitis—Cisplatin—bone cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Erythema—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Malnutrition—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—bone cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—bone cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Tension—Epirubicin—bone cancer	0.001	0.001	CcSEcCtD
Dexmethylphenidate—Nervousness—Epirubicin—bone cancer	0.000992	0.000992	CcSEcCtD
Dexmethylphenidate—Back pain—Epirubicin—bone cancer	0.000988	0.000988	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—bone cancer	0.000985	0.000985	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—bone cancer	0.000984	0.000984	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Epirubicin—bone cancer	0.000982	0.000982	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—bone cancer	0.00098	0.00098	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—bone cancer	0.00098	0.00098	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—bone cancer	0.000978	0.000978	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—bone cancer	0.000977	0.000977	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—bone cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—bone cancer	0.00097	0.00097	CcSEcCtD
Dexmethylphenidate—Nausea—Cisplatin—bone cancer	0.000964	0.000964	CcSEcCtD
Dexmethylphenidate—Vision blurred—Epirubicin—bone cancer	0.000962	0.000962	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—bone cancer	0.000959	0.000959	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—bone cancer	0.000952	0.000952	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—bone cancer	0.000951	0.000951	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Epirubicin—bone cancer	0.000947	0.000947	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—bone cancer	0.000945	0.000945	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—bone cancer	0.000945	0.000945	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—bone cancer	0.000945	0.000945	CcSEcCtD
Dexmethylphenidate—Anaemia—Epirubicin—bone cancer	0.000944	0.000944	CcSEcCtD
Dexmethylphenidate—Agitation—Epirubicin—bone cancer	0.000938	0.000938	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—bone cancer	0.000929	0.000929	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—bone cancer	0.000929	0.000929	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—bone cancer	0.000929	0.000929	CcSEcCtD
Dexmethylphenidate—Tension—Doxorubicin—bone cancer	0.000927	0.000927	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000922	0.000922	CcSEcCtD
Dexmethylphenidate—Malaise—Epirubicin—bone cancer	0.000921	0.000921	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—bone cancer	0.000918	0.000918	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—bone cancer	0.000918	0.000918	CcSEcCtD
Dexmethylphenidate—Vertigo—Epirubicin—bone cancer	0.000917	0.000917	CcSEcCtD
Dexmethylphenidate—Syncope—Epirubicin—bone cancer	0.000916	0.000916	CcSEcCtD
Dexmethylphenidate—Leukopenia—Epirubicin—bone cancer	0.000914	0.000914	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—bone cancer	0.000914	0.000914	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—bone cancer	0.000908	0.000908	CcSEcCtD
Dexmethylphenidate—Palpitations—Epirubicin—bone cancer	0.000902	0.000902	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—bone cancer	0.000898	0.000898	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Epirubicin—bone cancer	0.000897	0.000897	CcSEcCtD
Dexmethylphenidate—Cough—Epirubicin—bone cancer	0.000891	0.000891	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—bone cancer	0.00089	0.00089	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—bone cancer	0.00089	0.00089	CcSEcCtD
Dexmethylphenidate—Convulsion—Epirubicin—bone cancer	0.000885	0.000885	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—bone cancer	0.000885	0.000885	CcSEcCtD
Dexmethylphenidate—Hypertension—Epirubicin—bone cancer	0.000882	0.000882	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—bone cancer	0.000877	0.000877	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—bone cancer	0.000873	0.000873	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—bone cancer	0.000873	0.000873	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—bone cancer	0.000872	0.000872	CcSEcCtD
Dexmethylphenidate—Chest pain—Epirubicin—bone cancer	0.000869	0.000869	CcSEcCtD
Dexmethylphenidate—Myalgia—Epirubicin—bone cancer	0.000869	0.000869	CcSEcCtD
Dexmethylphenidate—Arthralgia—Epirubicin—bone cancer	0.000869	0.000869	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—bone cancer	0.000868	0.000868	CcSEcCtD
Dexmethylphenidate—Anxiety—Epirubicin—bone cancer	0.000866	0.000866	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—bone cancer	0.000865	0.000865	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000863	0.000863	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—bone cancer	0.000861	0.000861	CcSEcCtD
Dexmethylphenidate—Discomfort—Epirubicin—bone cancer	0.000859	0.000859	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—bone cancer	0.000852	0.000852	CcSEcCtD
Dexmethylphenidate—Dry mouth—Epirubicin—bone cancer	0.00085	0.00085	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—bone cancer	0.000849	0.000849	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—bone cancer	0.000849	0.000849	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—bone cancer	0.000847	0.000847	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—bone cancer	0.000846	0.000846	CcSEcCtD
Dexmethylphenidate—Confusional state—Epirubicin—bone cancer	0.00084	0.00084	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—bone cancer	0.000835	0.000835	CcSEcCtD
Dexmethylphenidate—Oedema—Epirubicin—bone cancer	0.000833	0.000833	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Epirubicin—bone cancer	0.000833	0.000833	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—bone cancer	0.00083	0.00083	CcSEcCtD
Dexmethylphenidate—Infection—Epirubicin—bone cancer	0.000828	0.000828	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—bone cancer	0.000824	0.000824	CcSEcCtD
Dexmethylphenidate—Shock—Epirubicin—bone cancer	0.00082	0.00082	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—bone cancer	0.000819	0.000819	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Epirubicin—bone cancer	0.000817	0.000817	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Epirubicin—bone cancer	0.000816	0.000816	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—bone cancer	0.000816	0.000816	CcSEcCtD
Dexmethylphenidate—Tachycardia—Epirubicin—bone cancer	0.000813	0.000813	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000811	0.000811	CcSEcCtD
Dexmethylphenidate—Skin disorder—Epirubicin—bone cancer	0.000809	0.000809	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Epirubicin—bone cancer	0.000806	0.000806	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—bone cancer	0.000805	0.000805	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—bone cancer	0.000804	0.000804	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—bone cancer	0.000804	0.000804	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—bone cancer	0.000804	0.000804	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—bone cancer	0.000802	0.000802	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—bone cancer	0.0008	0.0008	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—bone cancer	0.000795	0.000795	CcSEcCtD
Dexmethylphenidate—Anorexia—Epirubicin—bone cancer	0.000794	0.000794	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—bone cancer	0.000794	0.000794	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—bone cancer	0.000792	0.000792	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—bone cancer	0.000787	0.000787	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—bone cancer	0.000784	0.000784	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—bone cancer	0.000777	0.000777	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—bone cancer	0.000774	0.000774	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—bone cancer	0.000771	0.000771	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—bone cancer	0.000771	0.000771	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—bone cancer	0.000769	0.000769	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—bone cancer	0.000768	0.000768	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—bone cancer	0.000766	0.000766	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—bone cancer	0.000761	0.000761	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000759	0.000759	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—bone cancer	0.000759	0.000759	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—bone cancer	0.000756	0.000756	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—bone cancer	0.000755	0.000755	CcSEcCtD
Dexmethylphenidate—Insomnia—Epirubicin—bone cancer	0.000754	0.000754	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—bone cancer	0.000753	0.000753	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—bone cancer	0.000749	0.000749	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Epirubicin—bone cancer	0.000748	0.000748	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—bone cancer	0.000745	0.000745	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Epirubicin—bone cancer	0.000743	0.000743	CcSEcCtD
Dexmethylphenidate—Somnolence—Epirubicin—bone cancer	0.000741	0.000741	CcSEcCtD
Dexmethylphenidate—Anorexia—Doxorubicin—bone cancer	0.000735	0.000735	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—bone cancer	0.000734	0.000734	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Epirubicin—bone cancer	0.000734	0.000734	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—bone cancer	0.000728	0.000728	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Epirubicin—bone cancer	0.000724	0.000724	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Epirubicin—bone cancer	0.000719	0.000719	CcSEcCtD
Dexmethylphenidate—Fatigue—Epirubicin—bone cancer	0.000718	0.000718	CcSEcCtD
Dexmethylphenidate—Constipation—Epirubicin—bone cancer	0.000713	0.000713	CcSEcCtD
Dexmethylphenidate—Pain—Epirubicin—bone cancer	0.000713	0.000713	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—bone cancer	0.000707	0.000707	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—bone cancer	0.000704	0.000704	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—bone cancer	0.000704	0.000704	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000702	0.000702	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—bone cancer	0.000697	0.000697	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Doxorubicin—bone cancer	0.000692	0.000692	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—bone cancer	0.000687	0.000687	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Epirubicin—bone cancer	0.000687	0.000687	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—bone cancer	0.000685	0.000685	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Epirubicin—bone cancer	0.000681	0.000681	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—bone cancer	0.000679	0.000679	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—bone cancer	0.00067	0.00067	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000666	0.000666	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—bone cancer	0.000665	0.000665	CcSEcCtD
Dexmethylphenidate—Urticaria—Epirubicin—bone cancer	0.000662	0.000662	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—bone cancer	0.000659	0.000659	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—bone cancer	0.000659	0.000659	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Epirubicin—bone cancer	0.000659	0.000659	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Epirubicin—bone cancer	0.000659	0.000659	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Methotrexate—bone cancer	0.000656	0.000656	CcSEcCtD
Dexmethylphenidate—Asthenia—Methotrexate—bone cancer	0.000639	0.000639	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—bone cancer	0.000635	0.000635	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—bone cancer	0.00063	0.00063	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—bone cancer	0.00063	0.00063	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Epirubicin—bone cancer	0.000614	0.000614	CcSEcCtD
Dexmethylphenidate—Urticaria—Doxorubicin—bone cancer	0.000613	0.000613	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—bone cancer	0.00061	0.00061	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—bone cancer	0.00061	0.00061	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—bone cancer	0.000609	0.000609	CcSEcCtD
Dexmethylphenidate—Asthenia—Epirubicin—bone cancer	0.000598	0.000598	CcSEcCtD
Dexmethylphenidate—Pruritus—Epirubicin—bone cancer	0.00059	0.00059	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—bone cancer	0.000589	0.000589	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Epirubicin—bone cancer	0.00057	0.00057	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—bone cancer	0.000568	0.000568	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—bone cancer	0.000566	0.000566	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—bone cancer	0.000561	0.000561	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—bone cancer	0.000561	0.000561	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—bone cancer	0.000558	0.000558	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—bone cancer	0.000553	0.000553	CcSEcCtD
Dexmethylphenidate—Dizziness—Epirubicin—bone cancer	0.000551	0.000551	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—bone cancer	0.000546	0.000546	CcSEcCtD
Dexmethylphenidate—Vomiting—Epirubicin—bone cancer	0.00053	0.00053	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—bone cancer	0.000529	0.000529	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—bone cancer	0.000528	0.000528	CcSEcCtD
Dexmethylphenidate—Rash—Epirubicin—bone cancer	0.000525	0.000525	CcSEcCtD
Dexmethylphenidate—Dermatitis—Epirubicin—bone cancer	0.000525	0.000525	CcSEcCtD
Dexmethylphenidate—Headache—Epirubicin—bone cancer	0.000522	0.000522	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—bone cancer	0.00051	0.00051	CcSEcCtD
Dexmethylphenidate—Nausea—Epirubicin—bone cancer	0.000495	0.000495	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—bone cancer	0.00049	0.00049	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—bone cancer	0.000486	0.000486	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—bone cancer	0.000486	0.000486	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—bone cancer	0.000483	0.000483	CcSEcCtD
Dexmethylphenidate—Nausea—Doxorubicin—bone cancer	0.000458	0.000458	CcSEcCtD
